The FDA Clinical-Hold On Zafgen's Diabetes Drug May Be A Blessing - Seeking Alpha

The FDA Clinical-Hold On Zafgen's Diabetes Drug May Be A Blessing Seeking Alpha The FDA placed a clinical-hold on Zafgen's diabetes drug. If allowed to advance, it will require Zafgen to raise substantially more money. Zafgen has a second-generation drug for a rare genetic obesity condition in preclinical testing that will likely ... and more »

from diabetes - Google News